SAUDI ARABIA AND U.A.E. SIDE WITH RUSSIA AGAINST THE U.S.

To gain an edge, this is what you need to know now.

Ominous Development

Please click here for a chart of S&P 500 ETF (SPY) which represents the benchmark stock market index S&P 500 (SPX).

Note the following:

• The chart shows that the market sold off until about 11am ET.
• We shared with you in the Morning Capsule that the momo crowd was selling.
• As the bad news from OPEC+ hit, the chart shows that the momo crowd started buying stocks aggressively.
• We shared with you in advance that Saudi Arabia and the U.A.E. might side with Russia against the U.S.  Now it is official.  The U.S. alliance with Saudi Arabia has almost collapsed.  Saudi Arabia and U.A.E have picked a side – they chose Russia. 
• OPEC+ has decided to cut production by 2M bpd.
• Saudi Arabia and U.A.E siding with Russia has ominous geopolitical implications in addition to running up the price of oil.
• If the price of oil runs up, it will make it harder for the Fed to pivot.  This is negative for stocks.
  • Expect momo gurus to come up with a new narrative to persuade their followers to buy stocks ahead of the critical jobs report Friday morning.
• We previously shared with you that credit default swaps of Credit Suisse  (CS) were rising.  This was a significant negative development for stocks and Credit Suisse.  What did the momo crowd do?  In response, the momo crowd aggressively bought the entire market, and they also bought Credit Suisse stock. The news is that credit default swaps of UBS are also rising.  UBS is a very important Switzerland based global investment bank.  The media is oblivious.
• The VUD indicator is the most sensitive measure of net supply demand in real-time. The orange represents net supply and the green represents net demand.
• The chart shows the VUD indicator switched to green this afternoon, indicating net demand for stocks.

Money Flows

The momo crowd money flows since the Morning Capsule are 🔒 (To see the locked content, please take a 30 day free trial).

Smart money flows since the Morning Capsule are 🔒.

Short squeeze money flows are 🔒.

A Special Note To New Subscribers

Note the smart money behavior.  Smart money tends to sell into strength on strong up days.

New subscribers should consider adopting smart money’s way of investing and trading.

Sentiment

Sentiment is 🔒.

Sentiment is a contrary indicator at extremes.  In plain English, this means that when sentiment becomes extremely positive it is time to sell and when sentiment becomes extremely negative it is time to buy.

Close

Orders on close are indeterminable at this time.

There is merit to watching the pattern of market on close orders as they represent the day’s dominant net cumulative activity by many professionals and funds.

Gold

The momo crowd money flows in gold are 🔒 since the Morning Capsule.

Smart money flows are 🔒 in gold since the Morning Capsule.

Oil

The momo crowd money flows in oil are 🔒 since the Morning Capsule.

Smart money flows in oil are 🔒 since the Morning Capsule.

Buy Zones And Buy Now Ratings

Markets can generate substantial wealth for knowledgeable investors. NOW YOU TOO CAN ALSO SPECTACULARLY SUCCEED AT MEETING YOUR GOALS WITH THE HELP OF THE ARORA REPORT. You are receiving less than 2% of the content from our paid services. …TO RECEIVE THE REMAINING 98% INCLUDING MANY ATTRACTIVE INVESTMENT OPPORTUNITIES, TAKE A FREE TRIAL TO PAID SERVICES.

Please click here to take advantage of a FREE 30 day trial.

Nigam Arora

Nigam Arora is known for his accurate stock market calls. Nigam is a distinguished master of the macro. He is a popular columnist with over 100 million page views, an engineer, and nuclear physicist by background. Nigam has founded two Inc. 500 fastest growing companies and has been involved in over 50 entrepreneurial ventures. He is the developer of Theory ZYX of Successful Change Management and is the author of the book on Theory ZYX, as well as the developer of the ZYX Change Method for Investing.

Dr. Natasha Arora

Dr. Natasha Arora has significant expertise in investment analysis especially biotech, healthcare, and technology. Natasha is a graduate of Harvard Medical School followed by a postdoc at MIT. She has published several peer reviewed research papers in top science journals.